Real‐life effectiveness and safety of the daclatasvir/asunaprevir combination therapy for genotype 1b chronic hepatitis C patients: An emphasis on the pretreatment NS5A resistance‐associated substitution test-Reference-Cited by-同舟云学术

Real‐life effectiveness and safety of the daclatasvir/asunaprevir combination therapy for genotype 1b chronic hepatitis C patients: An emphasis on the pretreatment NS5A resistance‐associated substitution test

Published:2019-09-09 Issue:12 Volume:91 Page:2158-2165
ISSN:0146-6615
Container-title:Journal of Medical Virology
language:en
Short-container-title:J Med Virol

Author:

Jang Eun Sun¹^ORCID,Kim Kyung‐Ah²^ORCID,Kim Young Seok³^ORCID,Kim In Hee⁴^ORCID,Lee Byung Seok⁵^ORCID,Lee Youn Jae⁶,Chung Woo Jin⁷^ORCID,Jeong Sook‐Hyang¹^ORCID

Affiliation:

1. Department of Internal Medicine, Seoul National University College of MedicineSeoul National University Bundang Hospital Seongnam Gyeonggi Korea

2. Department of Internal MedicineInje University Ilsan Paik Hospital Goyang Gyeonggi Korea

3. Department of Internal Medicine, Soonchunhyang University Bucheon HospitalSoonchunhyang University College of Medicine Bucheon Gyeonggi Korea

4. Department of Internal Medicine, Chonbuk National University HospitalChonbuk National University College of Medicine Chonju Korea

5. Department of Internal MedicineChungnam National University College of Medicine Daejeon Korea

6. Department of Internal Medicine, Inje University Busan Paik HospitalInje University College of Medicine Busan Korea

7. Department of Internal MedicineKeimyung University School of Medicine Daegu Korea

Funder

Bristol-Myers Squibb

Publisher

Wiley

Subject

Infectious Diseases,Virology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/jmv.25575

Reference27 articles.

1. Global epidemiology of hepatitis C virus infection: New estimates of age-specific antibody to HCV seroprevalence

2. The global burden of viral hepatitis from 1990 to 2013: findings from the Global Burden of Disease Study 2013

3. A nationwide seroepidemiology of hepatitis C virus infection in South Korea

4. Clinical and epidemiological features of hepatitis C virus infection in South Korea: A prospective, multicenter cohort study

5. Type and cause of liver disease in Korea: single-center experience, 2005-2010

Cited by 1 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Next-generation sequencing analysis of hepatitis C virus resistance–associated substitutions in direct-acting antiviral failure in South Korea;Clinical and Molecular Hepatology;2023-04-01